Executing A Product Pivot With Vir Bio's Mark Eisner, MD
Business Of Biotech
00:00
Navigating Organizational Change in Biotech
This chapter addresses a significant reorganization within a biotech company, detailing site closures, layoffs, and the strategic acquisition of a T-cell engager platform from Sanofi. The speaker emphasizes the need to pivot priorities towards hepatitis programs while fostering a collaborative and innovative work environment. Insights into leadership styles, the integration of AI in drug discovery, and the shift from infectious diseases to oncology are also explored.
Transcript
Play full episode
